Literature DB >> 1656588

Measles virus phosphoprotein retains the nucleocapsid protein in the cytoplasm.

M Huber1, R Cattaneo, P Spielhofer, C Orvell, E Norrby, M Messerli, J C Perriard, M A Billeter.   

Abstract

Measles virus (MV) proteins were efficiently expressed in COS and Vero cells from vectors based on the strong cytomegalovirus enhancer-promoter and the simian virus 40 origin of replication. When expressed alone, nucleocapsid protein (N) migrates predominantly into the nucleus whereas phosphoprotein (P) is located in the cytoplasm. Coexpression of N and P proteins results in retention of the N protein in the cytoplasm, as seen also in infected cells. The retention of N protein is due to specific interactions with the P protein since coexpression of N with either the matrix or the hemagglutinin protein had no effect. Mapping of the regions of N-P interactions on P protein revealed that the carboxy-terminal 40% of P was sufficient for specific binding to N; however, the carboxy-terminal 60% of P was required for retention of N in the cytoplasm. Thus, the V and C proteins encoded within the first half of the P gene are not involved in the cytoplasmic retention of N protein. N protein might be fortuitously targeted to the nucleus as a result of its many basic amino acids, presumably destined to interact with the MV genome. However, this set of experiments has allowed to analyze in vivo the interactions between the N and P proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656588     DOI: 10.1016/0042-6822(91)90777-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  44 in total

1.  Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro.

Authors:  S M Horikami; J Curran; D Kolakofsky; S A Moyer
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  The UL25 protein of pseudorabies virus associates with capsids and localizes to the nucleus and to microtubules.

Authors:  K Kaelin; S Dezélée; M J Masse; F Bras; A Flamand
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Dynamics of viral RNA synthesis during measles virus infection.

Authors:  Sébastien Plumet; W Paul Duprex; Denis Gerlier
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription.

Authors:  Thorsten Reuter; Benedikt Weissbrich; Sibylle Schneider-Schaulies; Jürgen Schneider-Schaulies
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Tyrosine phosphorylation of measles virus P-phosphoprotein in persistently infected neuroblastoma cells.

Authors:  R Ofir; Y Weinstein; E Bazarsky; S Blagerman; M Wolfson; T Hunter; B Rager-Zisman
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

7.  Ribosomal frameshifting during translation of measles virus P protein mRNA is capable of directing synthesis of a unique protein.

Authors:  P Liston; D J Briedis
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Conformational maturation of measles virus nucleocapsid protein.

Authors:  A F Gombart; A Hirano; T C Wong
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  Measles Virus Forms Inclusion Bodies with Properties of Liquid Organelles.

Authors:  Yuqin Zhou; Justin M Su; Charles E Samuel; Dzwokai Ma
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

10.  Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed.

Authors:  Vincent H J Leonard; Patrick L Sinn; Gregory Hodge; Tanner Miest; Patricia Devaux; Numan Oezguen; Werner Braun; Paul B McCray; Michael B McChesney; Roberto Cattaneo
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.